Sequestrase chaperones protect against oxidative stress-induced protein aggregation and [ PSI + ] prion formation

Zorana Carter,Declan Creamer,Aikaterini Kouvidi,Chris M Grant,Chris M. Grant
DOI: https://doi.org/10.1371/journal.pgen.1011194
IF: 4.5
2024-03-02
PLoS Genetics
Abstract:Misfolded proteins are usually refolded to their functional conformations or degraded by quality control mechanisms. When misfolded proteins evade quality control, they can be sequestered to specific sites within cells to prevent the potential dysfunction and toxicity that arises from protein aggregation. Btn2 and Hsp42 are compartment-specific sequestrases that play key roles in the assembly of these deposition sites. Their exact intracellular functions and substrates are not well defined, particularly since heat stress sensitivity is not observed in deletion mutants. We show here that Btn2 and Hsp42 are required for tolerance to oxidative stress conditions induced by exposure to hydrogen peroxide. Btn2 and Hsp42 act to sequester oxidized proteins into defined PQC sites following ROS exposure and their absence leads to an accumulation of protein aggregates. The toxicity of protein aggregate accumulation causes oxidant sensitivity in btn2 hsp42 sequestrase mutants since overexpression of the Hsp104 disaggregase rescues oxidant tolerance. We have identified the Sup35 translation termination factor as an in vivo sequestrase substrate and show that Btn2 and Hsp42 act to suppress oxidant-induced formation of the yeast [ PSI + ] prion, which is the amyloid form of Sup35. [ PSI + ] prion formation in sequestrase mutants does not require IPOD (insoluble protein deposit) localization which is the site where amyloids are thought to undergo fragmentation and seeding to propagate their heritable prion form. Instead, both amorphous and amyloid Sup35 aggregates are increased in btn2 hsp42 mutants consistent with the idea that prion formation occurs at multiple intracellular sites during oxidative stress conditions in the absence of sequestrase activity. Taken together, our data identify protein sequestration as a key antioxidant defence mechanism that functions to mitigate the damaging consequences of protein oxidation-induced aggregation. Protein misfolding causes protein aggregation which is the abnormal association of proteins into larger aggregate structures. Protein aggregates can be toxic to cells and have been implicated in a wide variety of diseases. Protein sequestration has emerged as a key defence strategy which protects the proteome against an overload of misfolded proteins by partitioning them and protecting against potential cytotoxic effects. Previous studies have identified sequestrase chaperones that act to triage misfolded proteins to various spatially separated deposit sites in cells. We show here that sequestrases play a key role in mitigating the toxicity of protein aggregates specifically formed in response to oxidative stress. Using a yeast model, we show that sequestrases function to suppress oxidant-induced formation of prions, which are infectious agents formed by amyloid aggregates. Localization to the normal amyloid deposition site, termed the IPOD, is not required for prion formation in sequestrase mutants. The IPOD is thought to act as a site where prion proteins form their heritable form, and we propose that the high localized concentrations of multiple non-specific aggregates increases the likelihood of prion induction. This study has broad implications for understanding the role of oxidative protein damage as a trigger of prion and more general protein aggregate formation in eukaryotic cells.
genetics & heredity
What problem does this paper attempt to address?